Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 368.55
-3.75 (-1.01%)
At close: Feb 4, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 596.45 billion as of February 4, 2026. Its market cap has increased by 26.76% in one year.
Market Cap
596.45B
Enterprise Value
763.29B
Revenue
164.76B
Ranking
n/a
PE Ratio
94.40
Stock Price
368.55
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 596.45B, an increase of 1,213.39%. That is a compound annual growth rate of 12.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 596.45B | 13.47% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 330.14B |
| OneSource Specialty Pharma | 134.60B |
| Concord Biotech | 119.21B |
| Blue Jet Healthcare | 71.13B |
| Supriya Lifescience | 53.56B |
| Zota Health Care | 39.08B |
| Dishman Carbogen Amcis | 33.94B |
| Panacea Biotec | 22.48B |